The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997

被引:45
作者
Mocroft, A
Barry, S
Sabin, CA
Lepri, AC
Kinloch, S
Drinkwater, A
Lipman, M
Youle, M
Johnson, MA
Phillips, AN
机构
[1] UCL, Royal Free & Univ Coll Med Sch, Royal Free Ctr HIV Med, Dept Primary Care & Populat Sci, London NW3 2PF, England
[2] UCL, Royal Free & Univ Coll Med Sch, Dept Thorac Med, London NW3 2PF, England
关键词
hospital admissions; CD4 cell count; HAART; antiretroviral therapy; in-patient;
D O I
10.1097/00002030-199907090-00016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To describe the changes over time in incidence of hospital admissions among patients with HIV, reasons for hospital admission, duration of stay, relationship with CD4 T-cell count and with antiretroviral treatment. Methods: The incidence of hospital admissions during each calendar year from 1988 to 1997 inclusive was calculated using a person-years analysis. In addition the proportion of patient follow-up spent in hospital and the impact of changing treatment regimens among all patients with HIV aged greater than or equal to 14 years and with at least one CD4 T-cell count seen at the Royal Free Hospital, London was also described. Results: A total of 1806 patients were investigated with median follow-up of 21.1 months. Among all patients, the proportion of follow-up time spent as an in-patient decreased from 3.9% in 1988 to 1.3% in 1997 (P = 0.0015; test for trend). Hospital admissions for any cause peaked during 1989 at 72.0 per 100 patient years of follow-up (PYFU) and was 28.5 per 100 PYFU during 1997 (P < 0.0001; test for trend). There was a statistically significant decline in the proportion of follow-up time spent as an in-patient among patients with CD4 T-cell counts of less than or equal to 50 x 10(6)/l from > 30% before 1990 to < 5% during 1997 (P = 0.026; test for trend). Hospital admissions varied greatly according to treatment regimen; in 1996 and 1997 just 0.1% of follow-up time of patients on triple antiretroviral treatment regimens was spent as a hospital admission. Conclusions: Admissions to hospital began falling before the introduction of combination therapy and declined strikingly during 1996 and 1997 following the introduction of highly active antiretroviral therapy. These results have important implications for future allocation of resources and for patient management. (C) 1999 Lippincott Williams & Wilkins.
引用
收藏
页码:1255 / 1261
页数:7
相关论文
共 36 条
[1]  
[Anonymous], 1992, MMWR Recomm Rep, V41, P1
[2]  
[Anonymous], 1996, Lancet, V348, P283
[3]   CHANGING USE OF HOSPITAL SERVICES AND COSTS AT A LONDON AIDS REFERRAL CENTER, 1983-1989 [J].
BECK, EJ ;
KENNELLY, J ;
MCKEVITT, C ;
WHITAKER, L ;
WADSWORTH, J ;
MILLER, DL ;
EASMON, C ;
PINCHING, AJ ;
HARRIS, JRW .
AIDS, 1994, 8 (03) :367-377
[4]   THE RELATION BETWEEN HOSPITAL EXPERIENCE AND IN-HOSPITAL MORTALITY FOR PATIENTS WITH AIDS-RELATED PCP [J].
BENNETT, CL ;
GARFINKLE, JB ;
GREENFIELD, S ;
DRAPER, D ;
ROGERS, W ;
MATHEWS, C ;
KANOUSE, DE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (20) :2975-2979
[5]   Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease [J].
Cameron, DW ;
Heath-Chiozzi, M ;
Danner, S ;
Cohen, C ;
Kravcik, S ;
Maurath, C ;
Sun, E ;
Henry, D ;
Rode, R ;
Potthoff, A ;
Leonard, J .
LANCET, 1998, 351 (9102) :543-549
[6]   PNEUMOCYSTIS PROPHYLAXIS AND SURVIVAL IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION TREATED WITH ZIDOVUDINE [J].
CHAISSON, RE ;
KERULY, J ;
RICHMAN, DD ;
MOORE, RD .
ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (10) :2009-2013
[7]   COMBINATION THERAPY WITH ZIDOVUDINE AND DIDANOSINE COMPARED WITH ZIDOVUDINE ALONE IN HIV-1 INFECTION [J].
COLLIER, AC ;
COOMBS, RW ;
FISCHL, MA ;
SKOLNIK, PR ;
NORTHFELT, D ;
BOUTIN, P ;
HOOPER, CJ ;
KAPLAN, LD ;
VOLBERDING, PA ;
DAVIS, LG ;
HENRARD, DR ;
WELLER, S ;
COREY, L .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (08) :786-793
[8]  
Cooper DA, 1997, LANCET, V349, P1413, DOI 10.1016/S0140-6736(97)04441-3
[9]  
CROWE SM, 1991, J ACQ IMMUN DEF SYND, V4, P770
[10]   Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study [J].
Egger, M ;
Hirschel, B ;
Francioli, P ;
Sudre, P ;
Wirz, M ;
Flepp, M ;
Rickenbach, M ;
Malinverni, R ;
Vernazza, P ;
Battegay, M ;
Bernasconi, E ;
Burgisser, P ;
Erb, P ;
Fierz, W ;
Grob, P ;
Gruninger, U ;
Jeannerod, L ;
Ledergerber, B ;
Luthy, R ;
Matter, L ;
Opravil, M ;
Paccaud, F ;
Perrin, L ;
Pichler, W ;
Piffaretti, GC ;
Rutschmann, O ;
Zanetti, G .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7117) :1194-1199